Oxford Asset Management’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,747
Closed -$676K 1363
2019
Q4
$676K Buy
+5,747
New +$676K 0.02% 1077